Logo Lanfrica
  • Accueil
  • Atlas
  • Analyses
  • Documentation
  • Sign in

© 2026 Lanfrica. Tous droits réservés. Tous les droits d'auteur des ressources affichées sur le site Web Lanfrica appartiennent aux détenteurs de droits d'auteur d'origine, sauf indication contraire explicite.

Data Sheet 1_Mental health phenotypes of well-controlled HIV in Uganda.docx

Domaine:

healthcare

Type de record:

dataset
Créateur:
LeaKyuJacJul
Hôte:avatar
Introduction

The phenotypic expression of mental health (MH) conditions among people with HIV (PWH) in Uganda and worldwide are heterogeneous. Accordingly, there has been a shift toward identifying MH phenotypes using data-driven methods capable of identifying novel insights into mechanisms of divergent MH phenotypes among PWH. We leverage the analytic strengths of machine learning combined with inferential methods to identify novel MH phenotypes among PWH and the underlying explanatory features.

Methods

A total of 277 PWH (46% female, median age = 44; 93% virally suppressed [<50copies/mL]) were included in the analyses. Participants completed the Patient Health Questionnaire (PHQ-9), Beck Anxiety Inventory (BAI), and the PTSD Checklist-Civilian (PCL-C). A clustering pipeline consisting of dimension reduction with UMAP followed by HBDScan was used to identify MH subtypes using total symptom scores. Inferential statistics compared select demographic (age, sex, education), viral load, and early life adversity between clusters.

Results

We identified four MH phenotypes. Cluster 1 (n = 76; PTSD phenotype) endorsed clinically significant PTSD symptoms (average PCL-C total score > 33). Clusters 2 (n = 32; anxiety phenotype) and 3 (n = 130; mixed anxiety/depression phenotype) reported minimal PTSD symptoms, with modest BAI (Cluster 2) and PHQ-9 (Cluster 3) elevations. Cluster 4 (n = 39; minimal symptom phenotype) reported no clinical MH symptom elevations. Comparisons revealed higher rates of sexual abuse during childhood among the PTSD phenotype vs. the minimal symptom phenotype (p = 0.03).

Discussion

We identified unique MH phenotypes among PWH and confirmed the importance of early life adversity as an early risk determinant for unfavorable MH among PWH in adulthood.

Visit

figshare.com

Languages

Bai

Tags

Public Health and Health Services not elsewhere classifiedmental healthglobalUgandaHIVcognitiondepressionanxietyPTSD

Licenses

CC BY 4.0

Similaires

Data Sheet 1_Community-informed trial design and implementation to optimize recruitment and retention in low-income settings: lessons from rheumatic heart disease trials in Uganda.docxPersistently lower bone mass and bone turnover among South African children living with well controlled HIVData Sheet 1_Screening tools for maternal mental health in Africa: a systematic review.pdfData Challenge: Predicting AMR gene determinants and phenotypesData for: Young People’s use of Technology, and mental health and well-beingHemoglobin Phenotypes in Nigeria: Data From a National Reference Laboratory

Data Sheet 1_Community-informed trial design and implementation to optimize recruitment and retention in low-income settings: lessons from rheumatic heart disease trials in Uganda.docx

Research teams undertaking randomized clinical trials in low-and middle-income countries frequent

Persistently lower bone mass and bone turnover among South African children living with well controlled HIV

Objective: We evaluated longitudinal trends and associations between bone mass

Data Sheet 1_Screening tools for maternal mental health in Africa: a systematic review.pdf

Background

Maternal health during pregnancy and the postnatal period encompasses mental health, wh

Data Challenge: Predicting AMR gene determinants and phenotypes

Traditional methods like antimicrobial susceptibility testing (AST), mainly used for antimicrobial r

Data for: Young People’s use of Technology, and mental health and well-being

Data collected as part of a cross-sectional survey performed in Zimbabwe on young people’s use of te

Hemoglobin Phenotypes in Nigeria: Data From a National Reference Laboratory

Abstract On a global scale, 5% to 7% of the population carries an abnormal hemoglob